Mark Christopher Murray
CIK 1800013 · SVP - Acetyls · last filed 2026-03-03
Mark Christopher Murray is a SVP - Acetyls who has filed 20 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for CE, was dated Mar 3, 2026. Across all open-market trades the lifetime net is +$626.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.5M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$1.51M
2
20
$626.1K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CE | SVP - Acetyls | 28,279 | $53.48 | $1.51M | $626.1K | 16 | 2026-03-03 |
| Avantor, Inc. (AVTRpA) Delisted | EVP, Biomaterials & AT | 18,680 | $90.81 | $1.70M | $0 | 4 | 2022-01-18 |
Recent Filings
20 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-03-03 | CE | Grant (A) | +10,431 | $0 | EDGAR |
| 2026-02-18 | CE | Mixed | +848 | -$21.1K | EDGAR |
| 2025-08-18 | CE | Buy (P) | +2,017 | $84.4K | EDGAR |
| 2025-07-15 | CE | Tax (F) | −485 | -$29.5K | EDGAR |
| 2025-05-28 | CE | Buy (P) | +1,479 | $77.2K | EDGAR |
| 2025-03-10 | CE | Buy (P) | +2,353 | $128.1K | EDGAR |
| 2025-02-28 | CE | Grant (A) | — | $0 | EDGAR |
| 2025-02-19 | CE | Mixed | +507 | -$25.2K | EDGAR |
| 2024-07-16 | CE | Tax (F) | −471 | -$66.2K | EDGAR |
| 2024-03-11 | CE | Buy (P) | +597 | $93.4K | EDGAR |